Dimensional Fund Advisors LP Tenaya Therapeutics, Inc. Transaction History
Dimensional Fund Advisors LP
- $418 Billion
- Q2 2025
A detailed history of Dimensional Fund Advisors LP transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 73,408 shares of TNYA stock, worth $154,156. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,408
Previous 73,408
-0.0%
Holding current value
$154,156
Previous $41,000
7.32%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding TNYA
# of Institutions
94Shares Held
37MCall Options Held
91.4KPut Options Held
50.3K-
Column Group LLC San Francisco, CA9.4MShares$19.7 Million8.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.76MShares$9.99 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.07MShares$8.56 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$4.74 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.84MShares$3.87 Million0.0% of portfolio
About Tenaya Therapeutics, Inc.
- Ticker TNYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,364,700
- Market Cap $86.9M
- Description
- Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...